Pancreatic Acinar Cell Carcinoma Active Not Recruiting Phase 1 / 2 Trials for MK-1775 (DB11740)

IndicationStatusPhase
DBCOND0040329 (Pancreatic Acinar Cell Carcinoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02194829Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by SurgeryTreatment